Related Experiment Video
Updated: Jan 10, 2026

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice
Published on: October 24, 2018
Echinatin as a multimodal modulator of monoaminergic system: Preclinical evidence for antidepressant-like activity
Gizem Türkoğlu Sağlik1, Özgür Devrim Can1
1Anadolu University, Faculty of Pharmacy, Department of Pharmacology, Eskişehir, Türkiye.
Abstract:
Mounting evidence highlights flavonoids as multitarget candidates for central nervous system disorders because they can cross the blood-brain barrier and modulate diverse neurotransmitter pathways. Echinatin, a chalcone-type flavonoid from Glycyrrhiza species, has not previously been evaluated in behavioral models relevant to mood disorders. Here, we examined whether echinatin exerts antidepressant-like effects in validated rodent tests and explored the underlying monoaminergic mechanisms using pharmacological manipulations. Male BALB/c mice received echinatin (20 or 30 mg/kg), fluoxetine (10 mg/kg) or reboxetine (20 mg/kg). Antidepressant-like activity was assessed in the tail-suspension and modified forced-swimming tests, while motor performance was evaluated with the Rota-rod and the activity-meter. To delineate monoaminergic involvement, mice were pretreated with p-chlorophenylalanine (PCPA; serotonin synthesis inhibitor), α-methyl-p-tyrosine (AMPT; catecholamine synthesis inhibitor), WAY-100635 (serotonin 5-HT1A receptor antagonist), phentolamine (α-adrenoceptor antagonist), propranolol (β-adrenoceptor antagonist), SCH-23390 (dopamine D1 receptor antagonist), sulpiride (dopamine D2/D3 receptor antagonist) or ketanserin (serotonin 5-HT2A/5-HT2C receptor antagonist). Echinatin at 30 mg/kg markedly reduced immobility in both behavioral tests, producing effects comparable to reference antidepressants, without affecting locomotor activity or motor coordination. The anti-immobility effect was reversed by serotonergic (PCPA, WAY-100635), noradrenergic (AMPT, phentolamine, propranolol) and dopaminergic (SCH-23390, sulpiride) interventions, but was not altered by ketanserin. These findings provide the first pharmacological evidence that echinatin elicits antidepressant-like effects through broad monoaminergic modulation and support its further evaluation as a potential lead compound for antidepressant drug development.
More Related Videos
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Drugs Affecting Neurotransmitter Release or Uptake

